Smith & Nephew Plc
20 February 2004
20 February 2004
The Secretary
RNS
Old Broad Street
London
EC2N 1HP
Dear Sirs,
The Company has been informed that on 19 February 2004 Sir Christopher
O'Donnell, a director of Smith & Nephew plc, acquired 170,000 ordinary shares of
12 2/9p each through the exercise of executive share options at an exercise
price of 186.66p per share. 110,000 shares were subsequently sold at 514.67p, in
part to fund the subscription cost of the executive share options and a further
20,000 have been disposed of by way of gifts.
Sir Christopher also sold for 517.49p per share, 344,303 ordinary shares of 12
2/9p each following the exercise of nil-cost options granted under the Smith &
Nephew Long Term Incentive Plan.
Following the above Sir Christopher has a beneficial interest in 163,543
ordinary shares representing 0.020% of the issued share capital of the Company
and options over 190,509 ordinary shares representing 0.020% of the issued share
capital of the company.
Yours faithfully,
P.R. Chambers
Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.